E
Elias Anaissie
Researcher at University of Cincinnati
Publications - 373
Citations - 45035
Elias Anaissie is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Transplantation & Multiple myeloma. The author has an hindex of 107, co-authored 372 publications receiving 42808 citations. Previous affiliations of Elias Anaissie include Pennsylvania State University & Celgene.
Papers
More filters
Journal ArticleDOI
Cleaning Patient Shower Facilities: A Novel Approach to Reducing Patient Exposure to Aerosolized Aspergillus Species and Other Opportunistic Molds
Elias Anaissie,Shawna L. Stratton,M. C. Dignani,Choon Kee Lee,Tahsine H. Mahfouz,John H. Rex,Richard C. Summerbell,Thomas J. Walsh +7 more
TL;DR: It is shown that cleaning the floors of patient shower facilities in a bone marrow transplantation unit reduced the mean air concentrations of molds, including Aspergillus species.
Journal ArticleDOI
Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma.
Elizabeth Ann Coleman,Sharon K. Coon,Robert L. Kennedy,Kimberly D. Lockhart,Carol Beth Stewart,Elias Anaissie,Bart Barlogie +6 more
TL;DR: Exercise with prophylactic EPO therapy reduces the number of RBC transfusions and attempts at stem cell collection for patients receiving intensive treatment for multiple myeloma.
Journal ArticleDOI
Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method.
TL;DR: Am amphotericin B and natamycin were the most active agents tested and failed to show any inoculum size effect, and miconazole and itraconazole showed poor inhibitory and fungicidal activities, and the inoculum sizes had a major effect on the results.
Journal ArticleDOI
The Potential Role of Cytokine Therapy for Fungal Infections in Patients with Cancer: Is Recovery from Neutropenia all that is Needed?
TL;DR: Four cytokines show promise as adjuvant therapy for proven fungal infections in this setting and the concept of white blood cell transfusions has been revived by the use of granulocyte colony-stimulating factor and promises to be helpful in the setting of neutropenia.
Journal ArticleDOI
Fusarium. A newly recognized fungal pathogen in immunosuppressed patients.
Elias Anaissie,Elias Anaissie,Hagop M. Kantarjian,Paula G. Jones,Barthel Barlogie,Mario A. Luna,Gabriel‐Berestein ‐B Lopez,Gerald P. Bodey +7 more
TL;DR: This report and review of the recent literature suggest that Fusarium is emerging as a newly recognized fungal pathogen in immunosuppressed patients.